BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis
BTG4 is the last cloned and poorly studied member of BTG/Tob family. Studies have suggested that BTG4 is critical for the degradation of maternal mRNAs in mice during the process of maternal-to-zygotic transition, and downregulated in cancers, such as gastric cancer. However, the regulatory mechanis...
Main Authors: | Na Zhang, Tinghui Jiang, Yitao Wang, Lanyue Hu, Youquan Bu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/2/217 |
Similar Items
-
MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer
by: Ke Wei, et al.
Published: (2017-12-01) -
BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
by: Yibing Li, et al.
Published: (2020-10-01) -
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
by: Hua Chen, et al.
Published: (2018-01-01) -
MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway
by: Yingjun Xie, et al.
Published: (2019-01-01) -
LncRNA XIST Inhibits the Progression of Oral Squamous Cell Carcinoma via Sponging miR-455-3p/BTG2 Axis
by: Li Q, et al.
Published: (2020-11-01)